An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Akoya Biosciences, Inc. (Nasdaq: AKYA) will release financial results for the fourth quarter and full year of 2023 on March 4th, 2024. The company will host a conference call to discuss financial results at 5:00 p.m. ET. Akoya will also be participating in the upcoming BTIG at Snowbird: MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 13-14, 2024.
Positive
None.
Negative
None.
MARLBOROUGH, Mass., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the fourth quarter and full year of 2023 after the market close on March 4th, 2024. Company management will host a conference call to discuss financial results at 5:00 p.m. ET.
Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/.
Akoya will also be participating in the upcoming BTIG at Snowbird: MedTech, Digital Health, Life Science & Diagnostic Tools Conference taking place on February 13-14, 2024.
About Akoya Biosciences
As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com.
Akoya Biosciences will release financial results for the fourth quarter and full year of 2023 on March 4th, 2024.
The conference call to discuss financial results will take place at 5:00 p.m. ET.
Investors can listen to the conference call by registering online at least a day in advance. A live and archived webcast of the event will be available on the 'Investors' section of the Akoya website at https://investors.akoyabio.com/.
Akoya Biosciences will be participating in the BTIG at Snowbird: MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 13-14, 2024.
akoya biosciences is developing a novel high-parameter tissue analysis platform, at an order of magnitude beyond what is currently possible. our codex (tm) (co-detection by indexing) system enables deep proteomic profiling...all on your existing microscope. if you are a scientist or software engineer interested in revolutionizing the science of imaging, then akoya is the place for you. contact is at info@akoyabio.com.
